טוען...
Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves’ Disease
To determine the nature of TBIAb in Graves’ disease, TBIAb was measured and correlated to various clinical, thyroid functional indices and thyroid autoantibodies. The incidence of TBIAb in untreated Graves’ patients, patients in treatment and those in remission was 70.9%, 53.1% and 19.2%, respective...
שמור ב:
הוצא לאור ב: | Korean J Intern Med |
---|---|
Main Authors: | , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Korean Association of Internal Medicine
1988
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4532134/ https://ncbi.nlm.nih.gov/pubmed/2908684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.1988.3.1.45 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|